NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases

Innate immunity is a first line defence system in the body which is for sensing signals of danger such as pathogenic microbes or host-derived signals of cellular stress. Pattern recognition receptors (PRR’s), which present in the cell memebrane, are suspect the infection through pathogen-associated molecular patterns (PAMP), and activate innate immunity with response to promote inflammation via inflammatory cells such as macrophages and neutrophils, and cytokines. Inflammasome are protein complexes which are part of innate immunity in inflammation to remove pathogens and repair damaged tissues. What is the important role of inflammation in disease? In this review, we are focused on the action mechanism of NLRP3 inflammasome in inflammatory diseases such as asthma, atopic dermatitis, and sepsis.

[1]  Byung-Hyun Park,et al.  Atopic dermatitis-like skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes , 2018, Experimental & Molecular Medicine.

[2]  Xianming Deng,et al.  Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases , 2018, EMBO molecular medicine.

[3]  J. Hung,et al.  Der f1 induces pyroptosis in human bronchial epithelia via the NLRP3 inflammasome , 2017, International journal of molecular medicine.

[4]  T. Kanneganti,et al.  Mechanisms governing inflammasome activation, assembly and pyroptosis induction , 2017, International immunology.

[5]  Q. Lu,et al.  The Genetics and Epigenetics of Atopic Dermatitis—Filaggrin and Other Polymorphisms , 2016, Clinical Reviews in Allergy & Immunology.

[6]  Si Ming Man,et al.  Converging roles of caspases in inflammasome activation, cell death and innate immunity , 2015, Nature Reviews Immunology.

[7]  H. Fan,et al.  NLRP3 rs35829419 polymorphism is associated with increased susceptibility to multiple diseases in humans. , 2015, Genetics and molecular research : GMR.

[8]  C. Lam,et al.  NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation , 2015, Cellular and Molecular Immunology.

[9]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[10]  T. Cai,et al.  Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death , 2015, Nature.

[11]  Shangha Pan,et al.  Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. , 2014, International immunopharmacology.

[12]  P. Söderkvist,et al.  Genetic variation in the inflammasome and atopic dermatitis susceptibility. , 2013, The Journal of investigative dermatology.

[13]  E. Bel.  Clinical Practice. Mild asthma. , 2013, The New England journal of medicine.

[14]  G. Cheng,et al.  ASC/caspase‐1/IL‐1β signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia/reperfusion injury , 2013, Hepatology.

[15]  F. Fan,et al.  Resveratrol Inhibits Ionising Irradiation-Induced Inflammation in MSCs by Activating SIRT1 and Limiting NLRP-3 Inflammasome Activation , 2013, International journal of molecular sciences.

[16]  Qiang Xu,et al.  A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. , 2013, Biochemical pharmacology.

[17]  K. Kabashima.  New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. , 2013, Journal of dermatological science.

[18]  W. Land.  Transfusion-Related Acute Lung Injury: The Work of DAMPs* , 2013, Transfusion Medicine and Hemotherapy.

[19]  Hugo C van Woerden,et al.  Disruption of airway epithelium in asthma pathogenesis: are protozoa responsible? , 2012, Proceedings of the American Thoracic Society.

[20]  G. López-Castejón,et al.  Caspase-1: is IL-1 just the tip of the ICEberg? , 2012, Cell Death and Disease.

[21]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[22]  L. O’Neill,et al.  The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes , 2011, PloS one.

[23]  J. Zhu,et al.  Heme oxygenase-1 ameliorates LPS-induced acute lung injury correlated with downregulation of interleukin-33. , 2011, International immunopharmacology.

[24]  J. Tschopp,et al.  The inflammasome: an integrated view , 2011, Immunological reviews.

[25]  U. Sivaprasad,et al.  Th2 Cytokines and Atopic Dermatitis. , 2011, Journal of clinical & cellular immunology.

[26]  J. Tschopp,et al.  NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant , 2011, Allergy.

[27]  Anna K Rieger,et al.  Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome , 2011, The Journal of Immunology.

[28]  L. Joosten,et al.  Inflammasome activation and IL-1β and IL-18 processing during infection. , 2011, Trends in immunology.

[29]  Jonathan L. Schmid-Burgk,et al.  Inflammasomes: current understanding and open questions , 2011, Cellular and Molecular Life Sciences.

[30]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[31]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[32]  D. Davies.  The role of the epithelium in airway remodeling in asthma. , 2009, Proceedings of the American Thoracic Society.

[33]  P. Howarth,et al.  The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. , 2009, Proceedings of the American Thoracic Society.

[34]  G. Núñez,et al.  A Critical Role for Hemolysins and Bacterial Lipoproteins in Staphylococcus aureus-Induced Activation of the Nlrp3 Inflammasome1 , 2009, The Journal of Immunology.

[35]  M. Huang,et al.  NLRP3 (NALP3, Cryopyrin) Facilitates In Vivo Caspase-1 Activation, Necrosis, and HMGB1 Release via Inflammasome-Dependent and -Independent Pathways1 , 2009, The Journal of Immunology.

[36]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[37]  Seth L Masters,et al.  Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). , 2009, Annual review of immunology.

[38]  B. Cookson,et al.  Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.

[39]  M. Saleh,et al.  Molecular regulation of inflammation and cell death. , 2008, Cytokine.

[40]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[41]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[42]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[43]  M. Nothnagel,et al.  Polymorphisms in NACHT‐LRR (NLR) genes in atopic dermatitis , 2007, Experimental dermatology.

[44]  S. Akira,et al.  Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 , 2006, Nature.

[45]  E. Aberer,et al.  Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. , 2005, Journal of the American Academy of Dermatology.

[46]  P. Chanez.  Severe asthma is an epithelial disease , 2005, European Respiratory Journal.

[47]  M. Grunstein,et al.  Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle , 2004, European Respiratory Journal.

[48]  V. Dixit,et al.  Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf , 2004, Nature.

[49]  H. Hammad,et al.  Taking our breath away: dendritic cells in the pathogenesis of asthma , 2003, Nature Reviews Immunology.

[50]  P. Parnet,et al.  Maturation and Release of Interleukin-1β by Lipopolysaccharide-primed Mouse Schwann Cells Require the Stimulation of P2X7 Receptors* , 2003, Journal of Biological Chemistry.

[51]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[52]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[53]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[54]  R. Kolodner,et al.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.

[55]  Hiroshi Tanaka,et al.  IL-18 might reflect disease activity in mild and moderate asthma exacerbation. , 2001, The Journal of allergy and clinical immunology.

[56]  S. Holgate,et al.  Epithelial damage and response. , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[57]  C. Gabel,et al.  Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. , 1994, The Journal of biological chemistry.

[58]  G. Richards,et al.  The epidemiology of sepsis. , 1973, Clinical orthopaedics and related research.

[59]  A. Kligman,et al.  Staphylococcus aureus in psoriasis. , 1973, Archives of dermatology.

[60]  D. Erle,et al.  The airway epithelium in asthma. , 2019, Advances in immunology.

[61]  Donald Y M Leung,et al.  Recent insights into atopic dermatitis and implications for management of infectious complications. , 2010, The Journal of allergy and clinical immunology.

[62]  S. Mariathasan,et al.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation , 2007, Nature Reviews Immunology.

[63]  J. Rankin.  Biological mediators of acute inflammation. , 2004, AACN clinical issues.

[64]  M. Murcko,et al.  Structure and mechanism of interleukin-1 beta converting enzyme. , 1994, Nature.

[65]  Rakesh K. Kumar.  The Airway Epithelium , 1993 .

[66]  I I Lelis,et al.  [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.